Candesartan and kidney enlargement Patient Reports February 11, 2012



Candesartan Side Effects Report #4738560-3
Candesartan side effect was reported by a Health Professional from FRANCE on July 13, 2005. Female patient, weighting 7.05 lb, was diagnosed with essential hypertension and was treated with Candesartan. After drug was administered, patient experienced the following side effects: apgar score low, beta 2 microglobulin increased, congenital anomaly, delayed fontanelle closure, foetal disorder, haemoglobin decreased, kidney enlargement, kidney malformation. Candesartan dosage: unknown. During the same period patient was treated with METHYLDOPA. Patient recovered.

Candesartan Side Effects Report #5749700-1
Candesartan side effect was reported by a Health Professional from UNITED KINGDOM on May 21, 2008. Male patient, weighting 2.43 lb, was treated with Candesartan. After drug was administered, patient experienced the following side effects: anuria, bladder agenesis, foetal growth retardation, hypotension, kidney enlargement, single functional kidney. Candesartan dosage: unknown. During the same period patient was treated with BECLAMETHASONE, ALBUTEROL. Patient died.

Candesartan Side Effects Report #5765047-1
Candesartan side effect was reported by a Health Professional from UNITED KINGDOM on May 21, 2008. Male patient, weighting 2.43 lb, was treated with Candesartan. After drug was administered, patient experienced the following side effects: anuria, bladder agenesis, foetal growth retardation, hypotension, kidney enlargement, single functional kidney. Candesartan dosage: unknown. During the same period patient was treated with BECLAMETHASONE, ALBUTEROL. Patient died.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Candesartan